Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 mean » _ mean (Expand Search), a mean (Expand Search), i mean (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 mean » _ mean (Expand Search), a mean (Expand Search), i mean (Expand Search)
-
17961
-
17962
-
17963
-
17964
-
17965
-
17966
-
17967
-
17968
Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
Published 2018“…While screening off-target effects of rigid (<i>N</i>)-methanocarba-adenosine 5′-methylamides as A<sub>3</sub> adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). …”
-
17969
Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
Published 2018“…While screening off-target effects of rigid (<i>N</i>)-methanocarba-adenosine 5′-methylamides as A<sub>3</sub> adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). …”
-
17970
Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
Published 2018“…While screening off-target effects of rigid (<i>N</i>)-methanocarba-adenosine 5′-methylamides as A<sub>3</sub> adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). …”
-
17971
Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
Published 2018“…While screening off-target effects of rigid (<i>N</i>)-methanocarba-adenosine 5′-methylamides as A<sub>3</sub> adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). …”
-
17972
Mean number of visits and visit duration throughout larval development.
Published 2021“…<p>Larval development was split into six larval development days. <b>A.</b> While the mean number of visits increased from the first to the fifth development day, the mean visit duration decreased by two thirds in this timespan. …”
-
17973
-
17974
-
17975
Cytoskeletal disruption leads to a delay in the VEGFR2 response.
Published 2013“…<p>(A) Endothelial cells treated with cytoskeletal inhibitors Nocodazole or CCD show a loss of immediate ERK1/2 phosphorylation (pERK1/2) after 5 minutes of VEGF stimulation compared to controls while total ERK1/2 levels remain constant. …”
-
17976
-
17977
-
17978
Validation of hTERT mRNA as a direct target of miR-512-5p in CNE cells.
Published 2015“…(B) MiR-512-5p resulted in a significant decrease in luciferase expression in hTERT-3’UTR transfected cells compared with the scramble, while MiR-512-5p caused no statistical change in luciferase expression in mut-hTERT-3’UTR compared with the scramble(C) miR-512-5p mimic led to down-regulation of hTERT and TRF2 in CNE cells. …”
-
17979
Bald thigh syndrome in sighthounds—Revisiting the cause of a well-known disease
Published 2019“…Further research is required to clarify whether the <i>IGFBP5</i> variant represents a predisposing genetic risk factor. …”
-
17980